The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis

This meta-analysis aimed to determine the pooled association between polycystic ovary syndrome (PCOS), hypothyroidism, and fibrocystic breast changes. We searched important databases, including PubMed (Medline), Scopus, Web of Science, and Embase to retrieve all relevant studies published from 1990...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohnepoushi, Parisa, Dehghanbanadaki, Hojat, Mohammadzedeh, Pardis, Nikouei, Maziar, Moradi, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933953/
https://www.ncbi.nlm.nih.gov/pubmed/35305643
http://dx.doi.org/10.1186/s12935-022-02547-5
_version_ 1784671768716247040
author Kohnepoushi, Parisa
Dehghanbanadaki, Hojat
Mohammadzedeh, Pardis
Nikouei, Maziar
Moradi, Yousef
author_facet Kohnepoushi, Parisa
Dehghanbanadaki, Hojat
Mohammadzedeh, Pardis
Nikouei, Maziar
Moradi, Yousef
author_sort Kohnepoushi, Parisa
collection PubMed
description This meta-analysis aimed to determine the pooled association between polycystic ovary syndrome (PCOS), hypothyroidism, and fibrocystic breast changes. We searched important databases, including PubMed (Medline), Scopus, Web of Science, and Embase to retrieve all relevant studies published from 1990 to April 2021. The bias risk of selected articles was assessed based on the JBI checklist. Our search strategy yielded a total of 487 articles from the international databases. After screening their full-texts, 6 articles met the inclusion criteria and were considered for meta-analysis. The effect of PCOS on the incidence of fibrocystic breast changes was 2.49 (95% CI 1.85–3.34). Also, the effect of hypothyroidism on the incidence of fibrocystic breast changes was 1.90 (95% CI 0.92–3.93). The results showed that women with PCOS were at higher risks to develop fibrocystic breast changes.
format Online
Article
Text
id pubmed-8933953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89339532022-03-23 The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis Kohnepoushi, Parisa Dehghanbanadaki, Hojat Mohammadzedeh, Pardis Nikouei, Maziar Moradi, Yousef Cancer Cell Int Review This meta-analysis aimed to determine the pooled association between polycystic ovary syndrome (PCOS), hypothyroidism, and fibrocystic breast changes. We searched important databases, including PubMed (Medline), Scopus, Web of Science, and Embase to retrieve all relevant studies published from 1990 to April 2021. The bias risk of selected articles was assessed based on the JBI checklist. Our search strategy yielded a total of 487 articles from the international databases. After screening their full-texts, 6 articles met the inclusion criteria and were considered for meta-analysis. The effect of PCOS on the incidence of fibrocystic breast changes was 2.49 (95% CI 1.85–3.34). Also, the effect of hypothyroidism on the incidence of fibrocystic breast changes was 1.90 (95% CI 0.92–3.93). The results showed that women with PCOS were at higher risks to develop fibrocystic breast changes. BioMed Central 2022-03-19 /pmc/articles/PMC8933953/ /pubmed/35305643 http://dx.doi.org/10.1186/s12935-022-02547-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kohnepoushi, Parisa
Dehghanbanadaki, Hojat
Mohammadzedeh, Pardis
Nikouei, Maziar
Moradi, Yousef
The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title_full The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title_fullStr The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title_full_unstemmed The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title_short The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
title_sort effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933953/
https://www.ncbi.nlm.nih.gov/pubmed/35305643
http://dx.doi.org/10.1186/s12935-022-02547-5
work_keys_str_mv AT kohnepoushiparisa theeffectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT dehghanbanadakihojat theeffectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT mohammadzedehpardis theeffectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT nikoueimaziar theeffectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT moradiyousef theeffectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT kohnepoushiparisa effectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT dehghanbanadakihojat effectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT mohammadzedehpardis effectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT nikoueimaziar effectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis
AT moradiyousef effectofthepolycysticovarysyndromeandhypothyroidismontheriskoffibrocysticbreastchangesametaanalysis

Ejemplares similares